The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer TE Hickey, LA Selth, KM Chia, G Laven-Law, HH Milioli, D Roden, ... Nature medicine 27 (2), 310-320, 2021 | 151 | 2021 |
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent AD Ogunniyi, M Khazandi, AJ Stevens, SK Sims, SW Page, S Garg, ... PLoS One 12 (9), e0183457, 2017 | 41 | 2017 |
Non-canonical AR activity facilitates endocrine resistance in breast cancer KM Chia, H Milioli, N Portman, G Laven-Law, R Coulson, A Yong, ... Endocrine-related cancer 26 (2), 251-264, 2019 | 33 | 2019 |
Gonadotropin suppression in men leads to a reduction in claudin-11 at the Sertoli cell tight junction MJ McCabe, GA Tarulli, G Laven-Law, KL Matthiesson, SJ Meachem, ... Human Reproduction 31 (4), 875-886, 2016 | 20 | 2016 |
Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation GA Tarulli, G Laven-Law, R Shakya, WD Tilley, TE Hickey Journal of mammary gland biology and neoplasia 20, 75-91, 2015 | 20 | 2015 |
Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) ablation limits offspring viability and growth in mice LK Philp, TK Day, MS Butler, G Laven-Law, S Jindal, TE Hickey, HI Scher, ... Scientific reports 6 (1), 28950, 2016 | 14 | 2016 |
Androgen receptor signalling promotes a luminal phenotype in mammary epithelial cells GA Tarulli, G Laven-Law, M Shehata, KA Walters, IM Denis, MM Rahman, ... Journal of Mammary Gland Biology and Neoplasia 24, 99-108, 2019 | 7 | 2019 |
Epigenetic therapy suppresses endocrine-resistant breast tumour growth by re-wiring ER-mediated 3D chromatin interactions J Achinger-Kawecka, C Stirzaker, KM Chia, N Portman, E Campbell, Q Du, ... bioRxiv, 2021.06. 21.449340, 2021 | 6 | 2021 |
Abstract PD2-02: Combination CDK4/6 inhibition and AR agonism suppresses the growth of CDK4/6 inhibitor resistant breast cancers A Freelander, G Laven-Law, L Eshraghi, KM Chia, M Pickering, A Yong, ... Cancer Research 82 (4_Supplement), PD2-02-PD2-02, 2022 | 3 | 2022 |
Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer E Lim, TA Hickey, LA Selth, KM Chia, HH Milioli, D Roden, G Laven-Law, ... Cancer Research 80 (4_Supplement), GS2-03-GS2-03, 2020 | 2 | 2020 |
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer J Achinger-Kawecka, C Stirzaker, N Portman, E Campbell, KM Chia, Q Du, ... Nature Structural & Molecular Biology, 1-15, 2024 | 1 | 2024 |
Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer J Achinger-Kawecka, C Stirzaker, N Portman, E Campbell, K Chia, Q Du, ... | 1 | 2021 |
The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer L Hosseinzadeh, Z Kikhtyak, G Laven-Law, SM Pederson, CG Puiu, ... Genome biology 25 (1), 44, 2024 | | 2024 |
Selective inhibition of CDK9 in triple negative breast cancer EH Mustafa, G Laven-Law, Z Kikhtyak, V Nguyen, S Ali, AA Pace, R Iggo, ... Oncogene 43 (3), 202-215, 2024 | | 2024 |
Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherence G Laven‐Law, EL Symonds, JM Winter, G Chen, IH Flight, ... Journal of Gastroenterology and Hepatology, 2024 | | 2024 |
The Diagnostic Accuracy of a Fecal Immunochemical Test in Detecting Colorectal Cancer and Advanced Precancerous Colorectal Neoplasia in Patients with Iron Deficiency: A … J Pham, G Laven-Law, JM Winter, MM Wassie, C Cock, EL Symonds Gastroenterology Research and Practice 2023, 2023 | | 2023 |
FAECAL IMMUNOCHEMICAL TEST PLUS COLONOSCOPY FOR EARLY DETECTION OF ADVANCED NEOPLASIA IN INDIVIDUALS AT INCREASED RISK OF COLORECTAL CANCER: A DIAGNOSTIC ACCURACY AND PROGRAM … M Wassie, J Winter, G Young, R Fraser, G Laven-Law, C Cock, ... Gastrointestinal Endoscopy 97 (6), AB450, 2023 | | 2023 |
Hot Mail: Temperature Exposure during Mail Return of an Immunochemical Fecal Occult Blood Test G Laven-Law, D Bastin, RJL Fraser, C Cock, GP Young, JM Winter, ... Clinical Chemistry 69 (6), 615-626, 2023 | | 2023 |
Tu1131 USE OF METHYLATED CTDNA IN SURVEILLANCE AFTER TREATMENT FOR COLORECTAL CANCER EL Symonds, SK Pedersen, K Cornthwaite, ME Horsnell, M Lowe, ... Gastroenterology 164 (6), S-990, 2023 | | 2023 |
Abstract P4-08-16: Selective Androgen Receptor Modulators in combination with CDK4/6 inhibitors demonstrate anti-cancer activity in preclinical treatment resistant ER+ AR+ … A Freelander, G laven-Law, L Eshraghi, N Geetha, P Somerville, ... Cancer Research 83 (5_Supplement), P4-08-16-P4-08-16, 2023 | | 2023 |